The Ah receptor in stem cell cycling, regulation, and quiescence

Annals of the New York Academy of Sciences

Volumn 1310, Issue 1, 2014, Pages 44-50

  Gasiewicz, Thomas A ^a   Singh, Kameshwar P ^a   Bennett, J Allen ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Ah receptor; Hematopoietic stem cells; Quiescence

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; DIOXIN;

ARTICLE; BONE MARROW; CELL ACTIVATION; CELL ACTIVITY; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELLULAR IMMUNITY; CIRCADIAN RHYTHM; ENZYME REGULATION; GENE EXPRESSION; GENETIC REGULATION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; IMMUNE SYSTEM; IMMUNOREGULATION; KNOCKOUT MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PREMATURITY; PROTEIN FUNCTION; QUIESCENCE;

AH RECEPTOR; HEMATOPOIETIC STEM CELLS; QUIESCENCE;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNITY; MICE; MICE, KNOCKOUT; RECEPTORS, ARYL HYDROCARBON;

EID: 84896268602     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12361     Document Type: Article

References (52)

1. Poland, A. & J.C. Knutson. 1982. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22: 517-554.
2. Denison, M.S., A.A. Soshilov, G. He, et al. 2011. Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol. Sci. 124: 1-22.
3. Kerkvliet, N.I. et al. 2009. AHR-mediated immunomodulation: the role of altered gene transcription. Biochem. Pharmacol. 77: 746-760.
4. Marshall, N.B. & N. Kerkvliet. 2010. Dioxin and immune regulation: emerging role of the aryl hydrocarbon receptor in the generation of regulatory T cells. Ann. NY. Acad. Sci. 1183: 25-37.
5. Lindsey, S. & E.T. Papoutsakis. 2012. The evolving role of the aryl hydrocarbon receptor (AHR) in the normophysiology of hematopoiesis. Stem Cell Rev. 8: 1223-1235.
6. Hao, N. & M.L. Whitelaw. 2013. The emerging roles of AhR in physiology and immunity. Biochem. Pharmacol. 86: 561-570.
7. Quintana, F.J. & D.H. Sherr. 2013. Aryl hydrocarbon receptor control of adaptive immunity. Pharmacol. Rev. 65: 1148-1161.
8. Bertazzi, P.A., D. Consoni, S. Bachetti, et al. 2001. Health effects of dioxin exposure: a 20-years mortality study. Am. J. Epidemiol. 153: 1031-1044.
9. Viel, J.F., P. Arveux, J. Baverel & J.Y. Cahn. 2000. Soft-tissue sarcoma and non-Hodgkin's lymphoma clusters around a municipal solid waste incinerator with high dioxin emission levels. Am. J. Epidemiol. 152: 13-19.
10. Hayashibara, T., Y. Yamada, N. Mori, et al. 2003. Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ALT) leukemogenesis: constitutive activation of AHR in ALT. Biochem. Biophys. Res. Commun. 300: 128-134.
11. Mulero-Navarro, S., J.M. Carvajal-Gonzalez, M. Herranz, et al. 2006. The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding. Carcinogenesis 27: 1099-1104.
12. Rager, J.E. & R.C. Fry. 2012. The aryl hydrocarbon receptor pathways: a key component of the microRNA-mediated AML signalisome. Int. J. Environ. Res. Public Health 9: 1939-1953.
13. Monteleone, I., T.T. MacDonald, F. Pallone & G. Monteleone. 2012. The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis. Curr. Opin. Gastroenterol. 28: 310-313.
14. Benson, J.M. & D.M. Shepherd. 2011. Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease. Toxicol. Sci. 120: 68-78.
15. Zhang, I., J. Ma, M. Takeuchi, et al. 2010. Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor. Invest. Ophthal. Vis. Sci. 51: 2109-2117.
16. Baban, B., J.Y. Liu & M.S. Mozaffari. 2012. Aryl hydrocarbon receptor agonist, leflunomide, protects the ischemic-reperfused kidney: role of Tregs and stem cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 303: R1136-R1146.
17. Hu, W., J. Zhao & G. Pei. 2013. Activation of aryl hydrocarbon receptor (AhR) by Tranilast, an anti-allergy drug, promotes miR-302 expression and cell reprogramming. J. Biol. Chem. 288: 22972-22984.
18. Orford, K.W. & D.T. Scadden. 2008. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat. Rev. Genet. 9: 15-28.
19. Wilson, A., E. Laurenti, G. Oser, et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135: 1118-29.
20. Li, J. 2011. Quiescence regulators for hematopoietic stem cell. Exp. Hematol. 39: 511-520.
21. Oh, I.H. & R.K. Humphries. 2012. Concise review: multidimensional regulation of the hematopoietic stem cell state. Stem Cells 30: 82-88.
22. Rossi, D.J., C.H.M. Jamieson & I.L. Weissman. 2008. Stem cells and pathways to aging and cancer. Cell 132: 681-696.
23. Li, J. 2011. Quiescence regulators for hematopoietic stem cells. Exp. Hematol. 39: 511-520.
24. Waterstrat, A. & G. VanZant. 2009. Effects of aging on hematopoietic stem and progenitor cells. Curr. Opin. Immunol. 21: 408-413.
25. Jacob, B. & M. Osato. 2009. Stem cell exhaustion and leukemogenesis. J. Cell. Biochem. 107: 393-399.
26. Van Zant, G. & Y. Liang. 2012. Concise review: hematopoietic stem cell aging, life span, and transplantation. Stem Cell Trans. Med. 1: 651-657.
27. Dorshkind, K. & S. Swain. 2009. Age-associated declines in immune system development and function: causes, consequences, and reversal. Curr. Opin. Immunol. 21: 404-407.
28. Kramer, S., S.M. Hikel, K. Adams, et al. 2012. Current status of the epidemiologic evidence linking polychlorinated biphenyls and Non-Hodgkin lymphoma, and the role of immune dysregulation. Env. Health Perspect. 120: 1067-1075.
29. Garrett, R.W. & T.A. Gasiewicz. 2006. The aryl hydrocarbon receptor agonist 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin alters circadian rhythms, quiescence, and expression of clock genes in murine hematopoietic stem and progenitor cells. Mol. Pharmacol. 69: 2076-2083.
30. Fine, J.S., A.E. Silverstone & T.A. Gasiewicz. 1990. Impairment of prothymocyte activity by 2, 3, 7.8-tetrachlorodibenzo-p-dioxin. J. Immunol. 144: 1169-1176.
31. Murante, F.G. & T.A. Gasiewicz. 2000. Hematopoietic progenitor cells are sensitive targets to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in C57BL/6 mice. Toxicol. Sci. 54: 374-383.
32. Singh, K.P., A. Wyman, F.L. Casado, et al. 2009. Treatment of mice with the Ah receptor agonist and human carcinogen dioxin results in altered numbers and function of hematopoietic stem cells. Carcinogenesis 30: 11-19.
33. Sakai, R., T. Kujiume, H. Inoue, et al. 2003. TCDD treatment eliminates the long-term reconstitution activity of hematopoietic stem cells. Toxicol. Sci. 72: 84-91.
34. Staples, J.E., F.G. Murante, N.C. Fiore, et al. 1998. Thymic alterations induced by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin are strictly dependent on aryl hydrocarbon receptor activation in hematopoietic cells. J. Immunol. 160: 3844-3854.
35. Casado, F.L., K.P. Singh & T.A. Gasiewicz. 2011. Aryl hydrocarbon receptor activation in hematopoietic stem/progenitor cells alters cell function and pathway-specific gene modulation reflecting changes in cellular trafficking and migration. Mol. Pharmacol. 80: 673-682.
36. Thurmond, T.S., J.E. Staples, A.E. Silverstone & T.A. Gasiewicz. 2000. The aryl hydrocarbon receptor has a role in the in vivo maturation of murine bone marrow B lymphocytes and their response to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 165: 227-236.
37. Evans, C.A., R. Tonge, D. Blinco, et al. 2004. Comparative proteomics of primitive hematopoietic cell populations reveals differences in expression of proteins regulating motility. Blood 103: 3751-3759.
38. Shao, H.Y., Z.Y. Miao, Q.F.X. Hui-Chen, et al. 2011. Nucleophosmin gene mutations promote NIH3T3 cell migration and invasion through CXCR4 and MMPs. Exp. Mol. Pathol. 90: 553-560.
39. Fernandez-Salguero, P., T. Pineau, D.M. Hilbert, et al. 1995. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268: 722-726.
40. Schmidt, J.V., G.H. Su, J.K. Reddy, et al. 1996. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. USA 93: 6731-6736.
41. Mimura, J., K. Yamashita, K. Nakamura, et al. 1997. Loss of teratogenic response to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2: 645-654.
42. Fernandez-Salguero, P.M., J.M. Ward, J.P. Sundberg & F.J. Gonzalez. 1997. Lesions of aryl-hydrocarbon receptor-deficient mice. Vet. Pathol. 34: 605-614.
43. Hirabayashi, Y. & T. Inoue. 2009. Aryl hydrocarbon receptor biology and xenobiotic responses in hematopoietic progenitor cells. Biochem. Pharmacol. 77: 521-535.
44. Esser, C. 2009. The immune phenotype of AhR null mouse mutants: Not a simple mirror of xenobiotic receptor over-activation. Biochem. Pharmacol. 77: 597-607.
45. Singh, K.P., R.W. Garrett, F.L. Casado & T.A. Gasiewicz. 2011. Aryl hydrocarbon receptor-null allele mice have hematopoietic stem/progenitor cells with abnormal characteristics and functions. Stem Cells Develop. 20: 769-784.
46. Boitano, A.E., J. Wang, R. Romeo, et al. 2010. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329: 1348-1353.
47. Venezia, T.A., A.A. Merchant, C.A. Ramos, et al. 2004. Molecular signatures of proliferation and quiescence in hematopoietic stem cells. PLoS Biol. 2: e301.
48. Singh, K.P., J.A. Bennett, F.L. Casado, et al. 2013. Loss of aryl hydrocarbon receptor promotes gene changes associated with premature hematopoietic stem cell exhaustion and development of a myeloproliferative disorder in aging mice. Stem Cells Develop. 23: 95-106.
49. INK4a and Arf. Gene Dev. 22: 3115-3120.
50. INK4a mRNA with advancing age in acute myeloid leukemia. Aging 1: 949-953.
51. Jude, C.D., J.J. Gaudet, N.A. Speck & P. Ernst. 2008. Leukemia and hematopoietic stem cells: balancing proliferation and quiescence. Cell Cycle 7: 586-591.
52. Gazit, R., B.S. Garrison, T.N. Rao, et al. 2013. Transcriptome analysis identifies regulators of hematopoietic stem and progenitor cells. Stem Cell Rep. 1: 266-280.